
Form 8-K Current Report This report outlines iBio, Inc.'s Form 8-K filing, covering registrant details, financial results, and associated exhibits Registrant Information This section provides iBio, Inc.'s basic registrant information, including trading symbol, exchange, and report date - The report was filed by iBio, Inc. on May 2, 20252 Registrant Details | Category | Detail | | :--- | :--- | | Registrant Name | iBio, Inc. | | State of Incorporation | Delaware | | Commission File Number | 001-35023 | | Principal Executive Office | 11750 Sorrento Valley Road, Suite 200, San Diego, California 92121 | | Trading Symbol | IBIO | | Exchange | The Nasdaq Stock Market LLC | Item 2.02 Results of Operations and Financial Condition iBio, Inc. announced Q1 2025 financial results via a furnished press release, limiting legal liabilities - The company announced its financial results for the quarter ended March 31, 2025, through a press release issued on May 2, 20255 - The information in the press release (Exhibit 99.1) is considered "furnished" and not "filed," meaning it is not subject to the liabilities of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other SEC filings6 Item 9.01 Financial Statements and Exhibits This section lists Form 8-K exhibits, primarily the press release detailing the company's financial results Exhibits Furnished | Exhibit Number | Exhibit Description | | :--- | :--- | | 99.1 | Press Release, issued by iBio, Inc. dated May 2, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |